250 related articles for article (PubMed ID: 9257934)
1. Contrasting biophysical and pharmacological properties of T-type and R-type calcium channels.
Randall AD; Tsien RW
Neuropharmacology; 1997 Jul; 36(7):879-93. PubMed ID: 9257934
[TBL] [Abstract][Full Text] [Related]
2. Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967).
Bezprozvanny I; Tsien RW
Mol Pharmacol; 1995 Sep; 48(3):540-9. PubMed ID: 7565636
[TBL] [Abstract][Full Text] [Related]
3. Mibefradil (Ro 40-5967) blocks multiple types of voltage-gated calcium channels in cultured rat spinal motoneurones.
Viana F; Van den Bosch L; Missiaen L; Vandenberghe W; Droogmans G; Nilius B; Robberecht W
Cell Calcium; 1997 Oct; 22(4):299-311. PubMed ID: 9481480
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular T-type calcium channels: physiological and pharmacological significance.
Triggle DJ
J Hypertens Suppl; 1997 Dec; 15(5):S9-15. PubMed ID: 9481611
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of voltage- and use-dependent block of class A Ca2+ channels by mibefradil.
Aczél S; Kurka B; Hering S
Br J Pharmacol; 1998 Oct; 125(3):447-54. PubMed ID: 9806326
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibition of T-type Ca2+ channels by Ro 40-5967.
Mishra SK; Hermsmeyer K
Circ Res; 1994 Jul; 75(1):144-8. PubMed ID: 8013072
[TBL] [Abstract][Full Text] [Related]
7. Mibefradil inhibition of T-type calcium channels in cerebellar purkinje neurons.
McDonough SI; Bean BP
Mol Pharmacol; 1998 Dec; 54(6):1080-7. PubMed ID: 9855637
[TBL] [Abstract][Full Text] [Related]
8. Mibefradil, A T-type calcium channel antagonist in Y1 cells.
Esneu M; Gallo-Payet N; Payet MD
Endocr Res; 1998; 24(3-4):449-54. PubMed ID: 9888524
[TBL] [Abstract][Full Text] [Related]
9. Structure and functional characterization of a novel human low-voltage activated calcium channel.
Williams ME; Washburn MS; Hans M; Urrutia A; Brust PF; Prodanovich P; Harpold MM; Stauderman KA
J Neurochem; 1999 Feb; 72(2):791-9. PubMed ID: 9930755
[TBL] [Abstract][Full Text] [Related]
10. Biophysical and pharmacological characterization of voltage-dependent Ca2+ channels in neurons isolated from rat nucleus accumbens.
Churchill D; Macvicar BA
J Neurophysiol; 1998 Feb; 79(2):635-47. PubMed ID: 9463427
[TBL] [Abstract][Full Text] [Related]
11. Ca2+ channel actions of the non-dihydropyridine Ca2+ channel antagonist Ro 40-5967 in vascular muscle cells cultured from dog coronary and saphenous arteries.
Bian K; Hermsmeyer K
Naunyn Schmiedebergs Arch Pharmacol; 1993 Aug; 348(2):191-6. PubMed ID: 7694155
[TBL] [Abstract][Full Text] [Related]
12. Cloning and characterization of alpha1H from human heart, a member of the T-type Ca2+ channel gene family.
Cribbs LL; Lee JH; Yang J; Satin J; Zhang Y; Daud A; Barclay J; Williamson MP; Fox M; Rees M; Perez-Reyes E
Circ Res; 1998 Jul; 83(1):103-9. PubMed ID: 9670923
[TBL] [Abstract][Full Text] [Related]
13. The Ca(++)-channel blocker Ro 40-5967 blocks differently T-type and L-type Ca++ channels.
Mehrke G; Zong XG; Flockerzi V; Hofmann F
J Pharmacol Exp Ther; 1994 Dec; 271(3):1483-8. PubMed ID: 7996461
[TBL] [Abstract][Full Text] [Related]
14. T- and L-type Ca2+-channel antagonists reduce contractility in guinea pig cardiac myocytes.
Hoischen S; Brixius K; Schwinger RH
J Cardiovasc Pharmacol; 1998 Aug; 32(2):323-30. PubMed ID: 9700997
[TBL] [Abstract][Full Text] [Related]
15. Inhibition by mibefradil, a novel calcium channel antagonist, of Ca(2+)- and volume-activated Cl- channels in macrovascular endothelial cells.
Nilius B; Prenen J; Kamouchi M; Viana F; Voets T; Droogmans G
Br J Pharmacol; 1997 Jun; 121(3):547-55. PubMed ID: 9179399
[TBL] [Abstract][Full Text] [Related]
16. Distinctive biophysical and pharmacological properties of class A (BI) calcium channel alpha 1 subunits.
Sather WA; Tanabe T; Zhang JF; Mori Y; Adams ME; Tsien RW
Neuron; 1993 Aug; 11(2):291-303. PubMed ID: 8394721
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of ion permeation pathway in the N-type Ca2+ channel.
Wakamori M; Strobeck M; Niidome T; Teramoto T; Imoto K; Mori Y
J Neurophysiol; 1998 Feb; 79(2):622-34. PubMed ID: 9463426
[TBL] [Abstract][Full Text] [Related]
18. Effect of mibefradil on voltage-dependent gating and kinetics of T-type Ca(2+) channels in cortisol-secreting cells.
Gomora JC; Xu L; Enyeart JA; Enyeart JJ
J Pharmacol Exp Ther; 2000 Jan; 292(1):96-103. PubMed ID: 10604935
[TBL] [Abstract][Full Text] [Related]
19. NNC 55-0396 [(1S,2S)-2-(2-(N-[(3-benzimidazol-2-yl)propyl]-N-methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphtyl cyclopropanecarboxylate dihydrochloride]: a new selective inhibitor of T-type calcium channels.
Huang L; Keyser BM; Tagmose TM; Hansen JB; Taylor JT; Zhuang H; Zhang M; Ragsdale DS; Li M
J Pharmacol Exp Ther; 2004 Apr; 309(1):193-9. PubMed ID: 14718587
[TBL] [Abstract][Full Text] [Related]
20. Ca2+ currents in cerebellar granule neurones: role of internal Mg2+ in altering characteristics and antagonist effects.
Pearson HA; Sutton KG; Scott RH; Dolphin AC
Neuropharmacology; 1993 Nov; 32(11):1171-83. PubMed ID: 8107971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
